Clinical Trial Update: Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial completed evaluating bone markers as diagnostic tools for early detection of bone metastases in high-risk prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Novartis | Conditions: Prostate Cancer | Phase 4 | Status: COMPLETED